Regencell Bioscience Holdings Limited (RGC)

Last Closing Price: 22.16 (2026-06-04)

Stock-Based Compensation (Quarterly)

Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.

Regencell Bioscience Holdings Limited (RGC) Stock-Based Compensation data is not available.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Balance Sheet Financials
$2.36M
$0.18M
$0.66M
$3.01M
$1.67M
--
$0.13M
$1.79M
$1.22M
$1.22M
$1.22M
494.49M
Cash Flow Statement Financials
$-2.59M
$2.50M
--
$2.42M
$2.36M
$-0.06M
Stock-Based Compensation
--
--
--
Fundamental Metrics & Ratios
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--